(KV)
Live / Applied — Fourth extension granted (statement of use) (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 01 Dec 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97150686
- Mark type
- Design + words
- Filed
- 01 Dec 2021
- Published for opposition
- 16 Jan 2024
- Attorney of record
- DRAEKE H WESEMAN
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
Owner
- KALIVIR IMMUNOTHERAPEUTICS, INC., Pittsburgh, PA, US
- KALIVIR IMMUNOTHERAPEUTICS, INC., Pittsburgh, PA, US
Prosecution history
- 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2026 — SOU EXTENSION 4 GRANTED
- 09 Mar 2026 — SOU EXTENSION 4 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 3 GRANTED
- 10 Sept 2025 — SOU EXTENSION 3 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 2 GRANTED
- 12 Mar 2025 — SOU EXTENSION 2 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2024 — SOU EXTENSION 1 GRANTED
- 05 Sept 2024 — SOU EXTENSION 1 FILED